ALLMedicine™ Herpes Zoster Center

Aug 3rd, 2021 - This exploratory study estimates the economic value of the current vaccination program and increased coverage against four preventable diseases in older adults in the United States (US). A population-based, age-structured economic model was used t...

Aug 3rd, 2021 - Adults from racial and ethnic minorities and low-income groups are disproportionately affected by vaccine-preventable diseases. The objective of this study is to examine the trends in adult vaccination coverage in the U.S. by race/ethnicity and SE...

Jul 31st, 2021 - Varicella zoster virus is a Deoxyribonucleic acid (DNA) virus exclusively affecting humans. Reactivation of varicella zoster virus causes herpes zoster with vesicular eruptions in a restricted dermatomal distribution. Peripheral motor neuropathy i...

Jul 30th, 2021 - To compare event and incidence rates of herpes zoster (HZ), also known as shingles, in patients with rheumatoid arthritis under treatment with conventional synthetic (cs), targeted synthetic (ts) or biologic (b) disease-modifying antirheumatic dru...

Jul 30th, 2021 - The aim of the study was to assess if an association exists between cirrhosis and herpes zoster in Taiwan. A retrospective cohort study was designed to analyze the 2000-2013 claims dataset of 1 million insured residents who were randomly sampled f...

Jun 12th, 2013 - Neuropathic pain (NP) is often refractory to pharmacologic and noninterventional treatment. On behalf of the International Association for the Study of Pain Neuropathic Pain Special Interest Group, the authors evaluated systematic reviews, clinica...

Dec 7th, 2011 - Although vaccinations are most commonly associated with the pediatric population, it is important for healthcare professionals to be familiar with the vaccines that are recommended for adults. The authors discuss 3 vaccines-the measles, mumps, and...

Jun 6th, 2008 - These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of a live attenuated vaccine for the prevention of herpes zoster (zoster) (i.e., shingles) and its sequelae, which was licens...

Sep 30th, 2019 - Study participants were randomized to receive one of 3 consistency lots of V212, a high antigen lot of V212, or placebo. To comply with regulatory requests, results for all lots of V212 were combined for the primary and secondary efficacy and safe...

Sep 30th, 2019 - This is a randomized, double-blind, placebo-controlled study to assess the safety and tolerability of V212 when administered to adults with solid tumor malignancy (STM) receiving chemotherapy and to assess the impact of V212 on the development of ...

Sep 9th, 2019 - This is an open-label, randomized pilot trial to determine whether MMF given over 22 months meaningfully decreases the size of the HIV reservoir. At the University of Washington in Seattle, investigators will enroll 5 study participants who have b...

Sep 4th, 2019 - Herpes zoster (HZ) (Shingles) is a painful condition caused by reactivation of varicella zoster virus (VZV) that remains dormant after primary infection. HZ reactivation may cause significant morbidity such as post-herpetic neuralgia and even mort...

Sep 4th, 2019 - An observational, prospective cohort study of patients ≥ 50 years old with a Herpes Zoster (HZ) diagnosis, carried out by a national random sample of community first line practitioners concerned by HZ diagnosis: general practitioners, dermatologis...

Nov 25th, 2020 - Acute complications of herpes zoster (HZ) other than post-herpetic neuralgia (PHN) are relatively common, a new study suggests. Researchers conducted a cohort study of unvaccinated immunocompetent adults with incident HZ (n=178,964) and matched to...

Nov 23rd, 2020 - What is the next step in treatment after a person with rheumatoid arthritis fails to adequately respond to methotrexate — a Janus kinase (JAK) inhibitor or a biologic? That was the focus of a lively debate at the virtual annual meeting of the Amer...

Nov 13th, 2020 - (Reuters Health) - A once-daily 15 mg dose of upadacitinib for rheumatoid arthritis has similar rates of malignancies, serious infections, major adverse cardiovascular events, and venous thromboembolic events as other Janus kinase (JAK) inhibitors...

Oct 6th, 2020 - The adjuvanted recombinant zoster vaccine Shingrix appears to be effective in older adults with autoimmune diseases who are not receiving treatment regimens that suppress the immune system, according to a post hoc analysis of patients in two clini...

Sep 25th, 2020 - Question 1 of 2 Which of the following laboratory tests has the highest sensitivity, provides rapid results, and can be used to monitor treatment response when collected serially in patients with suspected herpes zoster? Your Peers Chose: VZV IgG ...